OCAM
ESLA icon

Owl Creek Asset Management’s Estrella Immunopharma ESLA Stock Holding History

Owl Creek Asset Management’s Portfolio ESLA Stock Details ESLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-255,000
Closed -$2.68M – 70
2023
Q3 		$2.68M Hold
255,000
– – 0.1% 27
2023
Q2 		$2.76M Hold
255,000
– – 0.13% 58
2023
Q1 		$2.7M Hold
255,000
– – 0.14% 77
2022
Q4 		$2.62M Buy
+255,000
New +$2.59M 0.09% 87

Other funds holding ESLA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return
HHGC
Hunting Hill Global Capital New York $129M AUM 17.34% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Owl Creek Asset Management's ESLA Position: Q4 2023 in Review

Owl Creek Asset Management sold out of Estrella Immunopharma (ESLA) in Q4 2023, closing a stake of 255,000 shares — an estimated $2.68M sold.

Owl Creek Asset Management first reported a position in ESLA in Q4 2022 and held it in 4 quarters. The position peaked at $2.76M in Q2 2023. 7 funds tracked by Wall St. Rank hold ESLA as of Q4 2023.

  • Owl Creek Asset Management reported no remaining Estrella Immunopharma position as of Q4 2023 after selling out during the quarter.
  • Owl Creek Asset Management sold 255,000 Estrella Immunopharma shares in Q4 2023, an estimated $2.68M.
  • Owl Creek Asset Management first reported a position in Estrella Immunopharma in Q4 2022 and held it in 4 quarters.
  • Owl Creek Asset Management's Estrella Immunopharma position peaked at $2.76M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Estrella Immunopharma as of Q4 2023.

Based on Owl Creek Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.